The #WalzLab revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could expand T cell therapies, bringing their benefits to a broader group of #cancer patients. #RockefellerScience #YearInReview
🔗: https://bit.ly/3L0r3vK
🔗: https://bit.ly/3L0r3vK
December 24, 2025 at 5:21 PM
The #WalzLab revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could expand T cell therapies, bringing their benefits to a broader group of #cancer patients. #RockefellerScience #YearInReview
🔗: https://bit.ly/3L0r3vK
🔗: https://bit.ly/3L0r3vK
A new study from the #WalzLab has revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could refine and expand T cell therapies, bringing their benefits to a much broader group of cancer patients.
This new understanding of T cell receptors may improve cancer immunotherapies
Researchers discovered that a crucial first step in the signaling system operates differently than previously thought, an insight that could lead to the next generation of treatments.
www.rockefeller.edu
December 16, 2025 at 9:05 PM
A new study from the #WalzLab has revealed key details about the T cell receptor, which is essential to T cell immunotherapies. The findings could refine and expand T cell therapies, bringing their benefits to a much broader group of cancer patients.